|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.5 SEK | +1.64% |
|
+1.40% | -28.49% |
Surgical Science Sweden AB (publ) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 197.69 million compared to SEK 39.6 million a year ago. Net income was SEK 66.89 million compared to SEK 10.56 million a year ago.
Basic earnings per share from continuing operations was SEK 1.32 compared to SEK 0.31 a year ago. Diluted earnings per share from continuing operations was SEK 1.31 compared to SEK 0.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.49% | 632M | |
| -2.39% | 30.38B | |
| +37.51% | 9.35B | |
| +35.03% | 4.45B | |
| -40.39% | 2.26B | |
| -6.10% | 1.66B | |
| -29.44% | 1.22B | |
| -41.27% | 1.01B | |
| -6.21% | 840M | |
| -49.31% | 707M |
SURGICAL SCIENCE SWEDEN AB 
